These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 21469439)

  • 1. Inhibition of galectins with small molecules.
    Oberg CT; Leffler H; Nilsson UJ
    Chimia (Aarau); 2011; 65(1-2):18-23. PubMed ID: 21469439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzymatic synthesis of non-natural trisaccharides and galactosides; Insights of their interaction with galectins as a function of their structure.
    Porciúncula González C; Cagnoni AJ; Mariño KV; Fontana C; Saenz-Méndez P; Irazoqui G; Giacomini C
    Carbohydr Res; 2019 Jan; 472():1-15. PubMed ID: 30428394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linear triazole-linked pseudo oligogalactosides as scaffolds for galectin inhibitor development.
    Dussouy C; Kishor C; Lambert A; Lamoureux C; Blanchard H; Grandjean C
    Chem Biol Drug Des; 2020 Oct; 96(4):1123-1133. PubMed ID: 32220037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rational Design and Synthesis of Methyl-β-d-galactomalonyl Phenyl Esters as Potent Galectin-8
    Patel B; Kishor C; Houston TA; Shatz-Azoulay H; Zick Y; Vinik Y; Blanchard H
    J Med Chem; 2020 Oct; 63(20):11573-11584. PubMed ID: 32809817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of a phenyl thio-beta-D-galactopyranoside library from 1,5-difluoro-2,4-dinitrobenzene: discovery of efficient and selective monosaccharide inhibitors of galectin-7.
    Cumpstey I; Carlsson S; Leffler H; Nilsson UJ
    Org Biomol Chem; 2005 May; 3(10):1922-32. PubMed ID: 15889175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galectin binding to cells and glycoproteins with genetically modified glycosylation reveals galectin-glycan specificities in a natural context.
    Nielsen MI; Stegmayr J; Grant OC; Yang Z; Nilsson UJ; Boos I; Carlsson MC; Woods RJ; Unverzagt C; Leffler H; Wandall HH
    J Biol Chem; 2018 Dec; 293(52):20249-20262. PubMed ID: 30385505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oligosaccharide specificity of galectins: a search by frontal affinity chromatography.
    Hirabayashi J; Hashidate T; Arata Y; Nishi N; Nakamura T; Hirashima M; Urashima T; Oka T; Futai M; Muller WE; Yagi F; Kasai K
    Biochim Biophys Acta; 2002 Sep; 1572(2-3):232-54. PubMed ID: 12223272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of a peptidic inhibitor that targets the dimer interface of a prototypic galectin.
    Vladoiu MC; Labrie M; Létourneau M; Egesborg P; Gagné D; Billard É; Grosset AA; Doucet N; Chatenet D; St-Pierre Y
    Oncotarget; 2015 Dec; 6(38):40970-80. PubMed ID: 26543238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galectin-13, a different prototype galectin, does not bind β-galacto-sides and forms dimers via intermolecular disulfide bridges between Cys-136 and Cys-138.
    Su J; Wang Y; Si Y; Gao J; Song C; Cui L; Wu R; Tai G; Zhou Y
    Sci Rep; 2018 Jan; 8(1):980. PubMed ID: 29343868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual thio-digalactoside-binding modes of human galectins as the structural basis for the design of potent and selective inhibitors.
    Hsieh TJ; Lin HY; Tu Z; Lin TC; Wu SC; Tseng YY; Liu FT; Hsu ST; Lin CH
    Sci Rep; 2016 Jul; 6():29457. PubMed ID: 27416897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition mechanism of human galectin-7 by a novel galactose-benzylphosphate inhibitor.
    Masuyer G; Jabeen T; Öberg CT; Leffler H; Nilsson UJ; Acharya KR
    FEBS J; 2012 Jan; 279(2):193-202. PubMed ID: 22059385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benzimidazole-galactosides bind selectively to the Galectin-8 N-Terminal domain: Structure-based design and optimisation.
    Hassan M; van Klaveren S; Håkansson M; Diehl C; Kovačič R; Baussière F; Sundin AP; Dernovšek J; Walse B; Zetterberg F; Leffler H; Anderluh M; Tomašič T; Jakopin Ž; Nilsson UJ
    Eur J Med Chem; 2021 Nov; 223():113664. PubMed ID: 34225180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of stable and selective inhibitors of human galectins-1 and -3.
    Giguère D; Bonin MA; Cloutier P; Patnam R; St-Pierre C; Sato S; Roy R
    Bioorg Med Chem; 2008 Aug; 16(16):7811-23. PubMed ID: 18674915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoprotective neo-glycoproteins: Chemoenzymatic synthesis of multivalent glycomimetics for inhibition of cancer-related galectin-3.
    Heine V; Hovorková M; Vlachová M; Filipová M; Bumba L; Janoušková O; Hubálek M; Cvačka J; Petrásková L; Pelantová H; Křen V; Elling L; Bojarová P
    Eur J Med Chem; 2021 Aug; 220():113500. PubMed ID: 33962190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding and cross-linking properties of galectins.
    Fred Brewer C
    Biochim Biophys Acta; 2002 Sep; 1572(2-3):255-62. PubMed ID: 12223273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arginine binding motifs: design and synthesis of galactose-derived arginine tweezers as galectin-3 inhibitors.
    Oberg CT; Leffler H; Nilsson UJ
    J Med Chem; 2008 Apr; 51(7):2297-301. PubMed ID: 18318467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Galectin Targeted Therapy in Oncology: Current Knowledge and Perspectives.
    Wdowiak K; Francuz T; Gallego-Colon E; Ruiz-Agamez N; Kubeczko M; Grochoła I; Wojnar J
    Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29320431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galectins: novel anti-inflammatory drug targets.
    Liu FT
    Expert Opin Ther Targets; 2002 Aug; 6(4):461-8. PubMed ID: 16353421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complex N-glycans are the major ligands for galectin-1, -3, and -8 on Chinese hamster ovary cells.
    Patnaik SK; Potvin B; Carlsson S; Sturm D; Leffler H; Stanley P
    Glycobiology; 2006 Apr; 16(4):305-17. PubMed ID: 16319083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3-(1,2,3-Triazol-1-yl)-1-thio-galactosides as small, efficient, and hydrolytically stable inhibitors of galectin-3.
    Salameh BA; Leffler H; Nilsson UJ
    Bioorg Med Chem Lett; 2005 Jul; 15(14):3344-6. PubMed ID: 15963723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.